Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Mildly Impaired Renal Function”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 13 of 0 results

Early research (Phase 1)Study completedNCT00805090
What this trial is testing

Open-Label, Single-Dose Study to Evaluate the Safety and PK of DIC075V in Subjects With Renal Insufficiency and Hepatic Impairment Compared to Healthy Subjects and Evaluate the Safety and Pharmacokinetics of HPβCD When Administered in DIC075V Compared to Sporanox® in Healthy Subjects

Who this might be right for
Renal Insufficiency, ChronicHepatic InsufficiencyHealthy
Javelin Pharmaceuticals 37
Early research (Phase 1)Ended earlyNCT04678505
What this trial is testing

Study of a Single Intravenous (IV) Dose of MK-3402 in Participants With Impaired Renal Function and in Healthy Controls (MK-3402-004)

Who this might be right for
Renal Impairment
Merck Sharp & Dohme LLC 9
Early research (Phase 1)Study completedNCT00543075
What this trial is testing

Pharmacokinetic Study of Genasense in Subjects With Normal Renal Function, Mildly Impaired Renal Function, and Moderately Impaired Renal Function

Who this might be right for
Normal Renal FunctionMildly Impaired Renal FunctionModerately Impaired Renal Function
Genta Incorporated 23
Early research (Phase 1)Study completedNCT03890770
What this trial is testing

Assess the Safety of Experimental Medication BMS986165 in Participants With Normal Kidney Function and Participants With Mild to End-Stage Kidney Disease.

Who this might be right for
Renal ImpairmentHealthy Volunteer
Bristol-Myers Squibb 44
Early research (Phase 1)Ended earlyNCT05487040
What this trial is testing

Measure the Amount of Study Medicine in Blood in Adult Participants With COVID-19 and Severe Kidney Disease

Who this might be right for
COVID-19
Pfizer 15
Early research (Phase 1)Study completedNCT00554450
What this trial is testing

Renal Impairment in Type 2 Diabetic Subjects

Who this might be right for
Diabetes Mellitus, Type 2
AstraZeneca 40
Testing effectiveness (Phase 2)Ended earlyNCT04987294
What this trial is testing

Phase IIa Study of ALLN-346 (Engineered Urate Oxidase) in Subjects With Hyperuricemia, Gout and Chronic Kidney Disease

Who this might be right for
HyperuricemiaGoutChronic Kidney Diseases
Allena Pharmaceuticals 19
Not applicableEnded earlyNCT03534141
What this trial is testing

Mild Hypothermia and Acute Kidney Injury in Liver Transplantation

Who this might be right for
CirrhosisEnd Stage Liver DiseaseAcute Kidney Injury+7 more
University of California, San Francisco 175
Not applicableNot Yet RecruitingNCT07160959
What this trial is testing

Physical Exercise to Prevent Mild-cognitive Impairment in Patients With Kidney Disfunctions

Who this might be right for
Chronic Kidney Disease (Stages 4 and 5)Mild Cognitive Impairment (MCI)
Biogem s.c.ar.l. 124
Early research (Phase 1)Study completedNCT06775834
What this trial is testing

Safety and Pharmacokinetics Study of HRS-1893 Tablets in Healthy Subjects and Those With Impaired Kidney Function

Who this might be right for
Hypertrophic Cardiomyopathy
Shandong Suncadia Medicine Co., Ltd. 24
Testing effectiveness (Phase 2)Study completedNCT00818571
What this trial is testing

Pharmacokinetics of Vildagliptin in Mild, Moderate and Severe Renal Impaired Patients

Who this might be right for
Renal ImpairmentDiabetes
Novartis Pharmaceuticals 96
Early research (Phase 1)Study completedNCT06380153
What this trial is testing

To Evaluate the Pharmacokinetics of Hemay005 Tablets in Patients With Renal Impairment

Who this might be right for
Psoriasis
Ganzhou Hemay Pharmaceutical Co., Ltd 26
Early research (Phase 1)Study completedNCT02536937
What this trial is testing

The Effects of Renal Impairment on the Pharmacokinetics and Tolerability of Eliglustat Tartrate

Who this might be right for
Gaucher Disease
Sanofi 32